Hemorrhoids
Conditions
Interventions
Intervention group:Fuzhiqing Ointment
Control group:Placebo ointment(Drug-free)
Sponsors
The Third People's Hospital of Chengdu
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Age =18 years old; (2) Patients diagnosed as internal hemorrhoids or mixed hemorrhoids according to the Guidelines for the Diagnosis and Treatment of Hemorrhoids in China (2020); (3) Patients who can be treated with polidocanol alone or in combination according to the researcher's evaluation; (4) Sign the informed consent form voluntarily and follow the requirements of the scheme.
Exclusion criteria
Exclusion criteria: (1) Patients who are allergic to any component of Fuzhiqing; (2) Patients with serious systemic diseases (especially untreated); (3) Patients with acute inflammatory reaction in anal region (anal infection abscess); (4) fever state; (5) Bronchial asthma or known allergic constitution; (6) serious and important organ diseases or autoimmune insufficiency; (7) Chronic inflammatory bowel disease (such as Crohn's disease); (8) Patients with known hypercoagulability; (9) Pregnant women lactating women or those who cannot use contraception during the study period; (10) Persons with a history of mental illness or neurological dysfunction; (11) Other circumstances that the researcher considers unsuitable to participate in the study.(1) Patients who are allergic to any component of Fuzhiqing; (2) Patients with serious systemic diseases (especially untreated); (3) Patients with acute inflammatory reaction in anal region (anal infection abscess); (4) fever state; (5) Bronchial asthma or known allergic constitution; (6) serious and important organ diseases or autoimmune insufficiency; (7) Chronic inflammatory bowel disease (such as Crohn's disease); (8) Patients with known hypercoagulability; (9) Pregnant women lactating women or those who cannot use contraception during the study period; (10) Persons with a history of mental illness or neurological dysfunction; (11) Other circumstances that the researcher considers unsuitable to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| effective rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| EQ-5D-3L;Prolapse;Blood;HDSS;Pain;itch; | — |
Countries
China
Contacts
Public ContactXiaoyingJiang
The Third People's Hospital of Chengdu
Outcome results
None listed